Journal
JOURNAL OF GENERAL VIROLOGY
Volume 94, Issue -, Pages 1127-1133Publisher
SOC GENERAL MICROBIOLOGY
DOI: 10.1099/vir.0.049221-0
Keywords
-
Categories
Funding
- NIH [1R15CA149690-01]
- Biomedical Sciences Program in the College of Health Sciences
- Midwestern University
- NATIONAL CANCER INSTITUTE [R15CA149690] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Epstein-Barr virus (EBV) latently infected B-cells are the precursors of EBV-associated malignancies. EBV-infection induces the production of pro-survival and anti-inflammatory cytokines that may be important in the transition between latency and malignancy. One EBV protein, LMP2A, can be detected in both latently infected resting B-cells and in EBV-associated malignancies. Therefore, we tested the ability of LMP2A to influence cytokine production using both LMP2A-Tg primary B-cells and LMP2A-expressing B-cell lines. Our data demonstrate that LMP2A does not globally alter B-cell-produced cytokine levels, but specifically targets IL-10. Additional studies using ELISA and real-time-RT-PCR confirm that LMP2A utilizes PI3-kinase to increase IL-10 levels. Finally, the data demonstrate that LMP2A-expressing B-cell lines are more dependent on IL-10 for survival in comparison to LMP2A-negative B-cell lines. These data identify a novel function of LMP2A in the alteration of a cytokine that is important for both tumour survival and anti-tumour responses.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available